DUBUQUE BANK & TRUST CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
DUBUQUE BANK & TRUST CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$224,000
-23.5%
1,6000.0%0.04%
-23.4%
Q2 2019$293,000
+15.4%
1,6000.0%0.05%
+14.6%
Q1 2019$254,000
+66.0%
1,6000.0%0.04%
+46.4%
Q4 2018$153,000
-32.3%
1,6000.0%0.03%
-20.0%
Q3 2018$226,000
-9.6%
1,6000.0%0.04%
-14.6%
Q2 2018$250,000
-13.8%
1,600
-11.1%
0.04%
-12.8%
Q1 2018$290,000
-2.7%
1,800
-0.6%
0.05%
+4.4%
Q4 2017$298,000
+127.5%
1,810
-13.8%
0.04%
+104.5%
Q3 2017$131,000
-21.6%
2,1000.0%0.02%
-38.9%
Q2 2017$167,0002,1000.04%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders